These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 6443315)

  • 1. Decreased A 23187-induced platelet aggregation in Duchenne muscular dystrophy.
    Bonadonna G; Corradina P; Lechi C; Zatti M; De Grandis D
    Muscle Nerve; 1984; 7(6):493-4. PubMed ID: 6443315
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet abnormalities in muscular dystrophy.
    Yarom R; Meyer S; More R; Liebergall M; Eldor A
    Thromb Haemost; 1983 Jun; 49(3):168-72. PubMed ID: 6308847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on hemorheological factors in pseudohypertrophic muscular dystrophy.
    Fukuda I; Yoshida T; Yoritsune H; Kiso T; Konishi S; Mozai T
    Bull Osaka Med Sch; 1978 Jul; 24(1):23-30. PubMed ID: 737358
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced sensitivity to calcium in Duchenne muscular dystrophy.
    Dise CA; Goodman DB; Lake WC; Hodson A; Rasmussen H
    Biochem Biophys Res Commun; 1977 Dec; 79(4):1286-92. PubMed ID: 341891
    [No Abstract]   [Full Text] [Related]  

  • 5. Red cell response to A23187 and valinomycine in Duchenne muscular dystrophy.
    Szibor R; Till U; Lösche W; Steinbicker V
    Acta Biol Med Ger; 1981; 40(9):1187-90. PubMed ID: 6803478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of platelet glass bead adhesion and platelet membrane glycoprotein IV (CD36) in Duchenne muscular dystrophy.
    Maurin N; Forst J; Leithe H; Forst R
    Thromb Haemost; 1998 May; 79(5):1067. PubMed ID: 9609256
    [No Abstract]   [Full Text] [Related]  

  • 7. Duchenne muscular dystrophy: alterations in lymphocyte fluidity.
    Ferretti G; Falcioni AM; Curatola G; Valentini B; Saccucci F
    Boll Soc Ital Biol Sper; 1983 Jul; 59(7):1035-40. PubMed ID: 6626329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duchenne muscular dystrophy. Morphological study of erythrocytes after treatment with L-alpha-lysophosphatidyl-choline in dystrophic patients and in the carrier state.
    Dellantonio R; Capriotti M; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G
    Acta Neurol Belg; 1981; 81(4):193-8. PubMed ID: 7293730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythrocyte membrane in Duchenne muscular dystrophy. I. Sensitivity to lysolecithin in dystrophic patients and their families].
    Grilli G; Bravi S; Angeleri F; Colombi A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2399-402. PubMed ID: 7470282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne muscular dystrophy: does serum myoglobin correlate with serum creatine kinase?
    Kiessling WR; Beckmann R
    Muscle Nerve; 1981; 4(3):257. PubMed ID: 7242564
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diurnal fluctuation of serum myoglobin concentration in progressive muscular dystrophy of Duchenne type (author's transl)].
    Konagaya M; Takayanagi T; Riku S; Sobue I
    Rinsho Shinkeigaku; 1981 Feb; 21(2):188-93. PubMed ID: 7196304
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum proteins & immunoglobulins in Duchenne muscular dystrophy.
    Ayesha Q; Malati T
    Indian J Med Res; 1985 Dec; 82():548-50. PubMed ID: 3833707
    [No Abstract]   [Full Text] [Related]  

  • 13. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
    Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythrocyte membrane in Duchenne muscular dystrophy. III. Modifications of acetylcholinesterase].
    Campagnoli P; Leporoni B; Bravi S; Lenaz G
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2408-13. PubMed ID: 7470283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoproteins in Duchenne muscular dystrophy.
    Arthur H; de Niese M; Jeffrey PL; Austin L
    Biochem Int; 1983 Mar; 6(3):307-13. PubMed ID: 6679326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological variations of erythrocytes in Duchenne muscular dystrophy and in carrier state.
    Capriotti M; Dellantonio R; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G; Leporoni B
    Boll Soc Ital Biol Sper; 1980 Jul; 56(14):1459-64. PubMed ID: 7448043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrocyte membrane protein in Duchenne muscular dystrophy (author's transl)].
    Herranz J; Mazo E; Arteaga R; Hermosa V; Zubizarreta A
    An Esp Pediatr; 1981 Nov; 15(5):433-42. PubMed ID: 7332144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood myoglobin in children with progressive muscular dystrophy and in carriers].
    Calandi C; Baretti S; Pacciani G; Bagni P; Borsotti M; Tozzi P; Adami Lami C
    Quad Sclavo Diagn; 1984 Dec; 20(4):391-8. PubMed ID: 6537549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.